TITLE

AUSSIE DMT BAN

PUB. DATE
August 2012
SOURCE
American Herb Association Quarterly Newsletter;Summer2012, Vol. 27 Issue 3, pp14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that the Australian Therapeutic Goods Administration has withdrawn a potential ban in May 2012 on the use of entheogenic plants containing dimethyltryptamine (DMT) by religions and native people.
ACCESSION #
79564875

 

Related Articles

  • Australian TGA updates safety info for varenicline.  // Reactions Weekly;8/7/2010, Issue 1313, p6 

    The article reports on an update issued by the Australian Therapeutic Goods Administration (TGA) on the safety of varenicline (Champix), including its associated psychiatric side effects.

  • Australian TGA warns of exenatide-induced pancreatitis.  // Reactions Weekly;6/5/2010, Issue 1304, p2 

    The article deals with the public advisory issued by the Australian Therapeutic Goods Administration (TGA) in June 2010 regarding exenatide-induced pancreatitis.

  • Combination antihypertensive approved.  // Australian Journal of Pharmacy;Apr2011, Vol. 92 Issue 1091, p52 

    The article offers information on the approval of the fixed-dose combination therapy, Twynsta, by the Therapeutic Goods Administration (TGA) in Australia.

  • TGA advises of dosing change for citalopram.  // Reactions Weekly;11/12/2011, Issue 1377, p3 

    The article reports on the recommendation by the Australian Therapeutic Goods Administration (TGA) that citalopram no longer be administered at dosages of less than 40 milligrams (mg)/day.

  • System for Australian Recall Actions.  // Australian Prescriber;Jun2013, Vol. 36 Issue 3, p95 

    The article offers information that the System for Australian Recall Actions (SARA), a website including a database of recall actions for therapeutic goods, has been launched by the Therapeutic Goods Administration (TGA), a regulatory agency of Australia for medical drugs and devices.

  • Changes to cough and cold medicines for use in children.  // Australian Prescriber;Jun2013, Vol. 36 Issue 3, p95 

    The article focuses on an advisory related to non-usage of cough medicines for children below six years of age and also informs about a change made to the database of Therapeutic Goods Administration (TGA), Australia's regulatory body for medical drugs, regarding the brain disease Leukodystrophy.

  • Australia's TGA and NZ's Medsafe to merge.  // PharmacoEconomics & Outcomes News;6/25/2011, Issue 631, p9 

    The article discusses the merging of Australia's Therapeutic Goods Administration (TGA) and New Zealand's Medsafe into a joint scheme to be named the Australia New Zealand Therapeutic Products Agency (ANZTPA) to regulate therapeutic goods and provide health benefits for consumers, reduce...

  • Australian TGA updates Pneumovax 23 advice.  // Reactions Weekly;1/14/2012, Issue 1384, p2 

    The article reports that the Australian Therapeutic Goods Administration (TGA), following the completion of a review of the Pneumorax 23 vaccine, has stated that a revaccination can be undertaken in accordance with the approved Product Information.

  • IVD Australia sees new regs as more expensive than forecast.  // Medical Device Daily;3/31/2010, Vol. 14 Issue 61, p1 

    This article announces the plan of Australia's Therapeutic Goods Administration (TGA) to start transitioning its regulatory structure for in vitro diagnostics in July 2010.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics